The latest updates on our research and how it is improving people’s lives.
The new Botnar strategy is announced
27 January 2023
After a year as the Director of the Botnar Institute for Musculoskeletal Sciences, Professor Jonathan Rees announces a new structure and strategy that will further enhance research and treatment of bone, joint and musculoskeletal conditions.
Sara Khalid named Associate Professor at NDORMS
26 January 2023
The University of Oxford has awarded the title of Associate Professor to Dr Sara Khalid as part of its recognition of excellence awards.
New global health grant to improve outcomes for patients with hip fracture
26 January 2023
Hip fracture patients in Low- and Middle-Income Countries (LMIC) in Asia are set to benefit from a new study that aims to bring best practice programmes to improve quality of life for patients and reduce healthcare costs.
NDORMS welcomes great-granddaughter of former Head of Department
20 January 2023
Julia Strubell, great-granddaughter of Professor Josep Trueta, visited NDORMS to find out about his time here and to share her own work with staff and students.
Botnar researchers awarded Fellowships
9 January 2023
Arani Vivekanantham has been awarded an NIHR Doctoral Fellowship and a Versus Arthritis Clinical Research Fellowship, and Rachel Kuo was awarded an NIHR Doctoral Research Fellowship.
Better diagnosis and treatment of autoimmune diseases moves a step closer
5 January 2023
A study published in Nature outlines a way to find the crucial peptides (protein fragments) that drive autoimmunity, as well as the immune cells that respond to them.
New drug offers hope for people with hand osteoarthritis
22 December 2022
A new study, published in Science Translational Medicine by researchers at the University of Oxford has identified that Talarozole, a drug that is known to increase retinoic acid, was able to prevent osteoarthritis (OA) in disease models.
Professor Michael Dustin appointed new Chair in Molecular Immunology
6 December 2022
A generous gift from the Kennedy Trust for Rheumatology Research has enabled the creation of a new Chair in Molecular Immunology at the University of Oxford.
Empowering data science for single-cell analysis in Zimbabwe
5 December 2022
An innovative computational biology training module was launched in November 2022 at the African Institute of Biomedical Science and Technology (AiBST) in Harare, Zimbabwe, where MSc students were trained in single-cell RNA sequencing data analysis.
T-cell coreceptors are well endowed—with kinases!
2 December 2022
The kinase occupancy of CD4 and CD8 coreceptors is high, according to a new study published in PNAS.
Two prestigious Hunterian Professorships awarded to NDORMS researchers
1 December 2022
Conrad Harrison and Tom Layton have both been awarded Hunterian Professorships for 2022 by the Royal College of Surgeons of England
Adalimumab is found to be a cost-effective treatment for early-stage Dupuytren’s disease
15 November 2022
Researchers at the Kennedy Institute of Rheumatology and Oxford Population Health’s Health Economics Research Centre have found that anti-TNF treatment (adalimumab) is likely to be a cost-effective treatment for people affected by early-stage Dupuytren’s disease.
Patients like me
1 November 2022
What can patients learn from the experiences of people like them who’ve already had a hip replacement? A new tool called ‘Patients like me’ helps answer some of the questions about pain, complications and how long the prosthesis might last.
Study reveals new evidence on rare blood-clotting condition after covid-19 vaccination
28 October 2022
Researchers from NDORMS at the University of Oxford have investigated claims that some adenovirus-based COVID-19 vaccines increase the risk of rare blood clots compared to their mRNA-based counterparts.
NDORMS contributes to new UK research to tackle monkeypox outbreak
25 October 2022
The UK’s efforts to tackle the monkeypox outbreak will receive a huge boost with the creation of a new research consortium and a new study to study vaccine effectiveness.
World Osteoporosis Day 2022
20 October 2022
A bone-healthy lifestyle is vital for strong bones and a mobile, fracture-free future. On World Osteoporosis Day, we are sharing advice from the International Osteoporosis Foundation (IOF), on putting your bone health first.
Mathematician boosts data science research at the Kennedy Institute
19 October 2022
Welcome to Yang Luo who has joined the Kennedy Institute as the Principal Investigator of the Luo Group. Her lab is leading the investigation into how genetic variations contribute to diseases of the immune system.
Leducq Foundation grant boosts cardiovascular research
11 October 2022
The Leducq Foundation has awarded $7.5 million to researchers at the University of Oxford and their collaborators to advance immunotherapy as a treatment for cardiovascular disease, the leading cause of death in the UK.
MRC funding awarded to Kennedy researchers
8 September 2022
Two new projects led by Tal Arnon and Irina Udalova have been awarded Medical Research Council (MRC) funding.
Daniel Prieto-Alhambra receives ISPE award for COVID-19 research
1 September 2022
Daniel Prieto-Alhambra has been awarded the 'Special ISPE award for contributions to public health associated with the COVID-19 pandemic.'